What Adaptive Biotechnologies Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 69 | 184 |
| Total trades | 112 | 343 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 805,805 | 5,410,790 |
| Disposed | 962,983 | 7,247,335 |
| Net activity | −157,178 | −1,836,545 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rubinstein Julie | President and COO | Nov 13 | Disclosed 10b5-1 sale · S | −11,466 | $28.93 | −$332K | 377,802 |
| Rubinstein Julie | President and COO | Nov 13 | Exercise / conversion · M | +11,466 | $12.14 | +$139K | 389,268 |
| Rubinstein Julie | President and COO | Nov 12 | Disclosed 10b5-1 sale · S | −11,881 | $29.40 | −$349K | 377,802 |
| Rubinstein Julie | President and COO | Nov 12 | Exercise / conversion · M | +11,881 | $12.14 | +$144K | 389,683 |
| Rubinstein Julie | President and COO | Nov 11 | Disclosed 10b5-1 sale · S | −6,898 | $31.22 | −$215K | 377,802 |
| Rubinstein Julie | President and COO | Nov 11 | Disclosed 10b5-1 sale · S | −4,983 | $30.29 | −$151K | 384,700 |
| Rubinstein Julie | President and COO | Nov 11 | Exercise / conversion · M | +11,881 | $12.14 | +$144K | 389,683 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Nov 11 | Disclosed 10b5-1 sale · S | −1,875 | $32.00 | −$60K | 387,475 |
| Rubinstein Julie | President and COO | Nov 10 | Disclosed 10b5-1 sale · S | −1,900 | $30.41 | −$57.8K | 377,802 |
| Rubinstein Julie | President and COO | Nov 10 | Disclosed 10b5-1 sale · S | −9,981 | $29.35 | −$293K | 379,702 |
| Rubinstein Julie | President and COO | Nov 10 | Exercise / conversion · M | +11,881 | $12.14 | +$144K | 389,683 |
| Robins Chad M | CEO and Chairman | Nov 09 | Gift · G | −100,000 | — | — | 2,080,518 |
| Rubinstein Julie | President and COO | Nov 09 | Disclosed 10b5-1 sale · S | −2,400 | $30.58 | −$73.4K | 377,802 |
| Rubinstein Julie | President and COO | Nov 09 | Disclosed 10b5-1 sale · S | −8,381 | $30.15 | −$253K | 380,202 |
| Rubinstein Julie | President and COO | Nov 09 | Disclosed 10b5-1 sale · S | −1,100 | $28.87 | −$31.8K | 388,583 |
| Rubinstein Julie | President and COO | Nov 09 | Exercise / conversion · M | +11,881 | $12.14 | +$144K | 389,683 |
| Rubinstein Julie | President and COO | Nov 06 | Disclosed 10b5-1 sale · S | −3,481 | $27.88 | −$97.1K | 377,802 |
| Rubinstein Julie | President and COO | Nov 06 | Disclosed 10b5-1 sale · S | −8,400 | $27.32 | −$229K | 381,283 |
| Rubinstein Julie | President and COO | Nov 06 | Exercise / conversion · M | +11,881 | $12.14 | +$144K | 389,683 |
| Rubinstein Julie | President and COO | Nov 05 | Disclosed 10b5-1 sale · S | −500 | $27.70 | −$13.9K | 377,802 |
Loading...